• Exchange: ASE
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

CSL:AU

67.3500 AUD 0.2000 0.30%

As of 02:10:11 ET on 07/24/2014.

Snapshot for CSL Ltd (CSL)

Open: 67.3900 Day's Range: 67.1800 - 67.4900 Volume: 1,167,985
Previous Close: 67.1500 52wk Range: 62.8300 - 72.8200 1-Yr Rtn: +3.76%

Stock Chart for CSL

No chart data available.
  • CSL:AU 67.3500
  • 1D
  • 1M
  • 1Y
67.1500
Interactive CSL Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CSL

Current P/E Ratio (ttm) 25.1633
Estimated P/E(06/2014) 22.8583
Relative P/E vs. AS51 1.2733
Earnings Per Share (USD) (ttm) 2.5223
Est. EPS (USD) (06/2014) 2.7770
Est. PEG Ratio 1.7886
Market Cap (M AUD) 32,047.51
Shares Outstanding (M) 475.84
30 Day Average Volume 1,246,616
Price/Book (mrq) 9.3220
Price/Sale (ttm) 6.1580
Dividend Indicated Gross Yield 1.72%
Cash Dividend (AUD) 0.5888
Dividend Ex-Date 03/05/2014
5 Year Dividend Growth 16.93%
Next Earnings Announcement 08/13/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CSL

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for CSL

CSL Limited develops, manufactures and markets human pharmaceutical and diagnostic products derived from human plasma. The Company's products include pediatric and adult vaccines, infection and pain medicine, skin disorder remedies, antivenoms, anticoagulants and immunoglobulins.

John ShineChairmanHan Willem KottermanVice Chairman
Paul PerreaultCEO/Managing DirectorGordon NaylorChief Financial Officer
More Company Profile & Key Executives for CSL

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil